跳至主要内容
临床试验/ISRCTN28276837
ISRCTN28276837已完成未知

The effect of magnetic resonance imaging localisation of prostate cancer on transrectal ultrasound biopsy detection rate

Department of Health0 个研究点目标入组 122 人开始时间: 2005年9月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
122

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • All patients who are to have a transrectal ultrasound (TRUS) biopsy (on a Thursday) to confirm prostate cancer, with an intermediate PSA level (10-19 ng/ml), will be eligible for entry to the study. On average 8 patients undergo TRUS biopsy at Cookridge Hospital per week (divided between Tuesday and Thursday morning sessions). One MRI slot per week (Thursday morning) will be available for the study. All consenting patients will be randomised and one selected for the MRI cohort and all others will form the non-MRI cohort. Assuming at least 2 patients are recruited a week (50%) recruitment rate) the two cohorts (61 patients in each) will be recruited in 61 weeks.

排除标准

  • 1. Unwilling/unable to give informed consent
  • 2. Significant claustrophobia
  • 3. Contra indications to MRI: pacemaker, aneurysm clips, metallic foreign bodies in the eye

研究者

相似试验